

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.34829766 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.34829766 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99890852 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.99890852 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.48412481 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.85925959 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.73845236 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.73845236 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.73845236 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.65560836 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.54261448 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.51707279 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51495446 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.46313773 |
| 15 | cysteine metabolic process (GO:0006534) | 5.28974564 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.12607584 |
| 17 | urea metabolic process (GO:0019627) | 5.11344952 |
| 18 | urea cycle (GO:0000050) | 5.11344952 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.08372449 |
| 20 | protein carboxylation (GO:0018214) | 5.01291556 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01291556 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.93152506 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92149310 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.88735985 |
| 25 | bile acid metabolic process (GO:0008206) | 4.83658658 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.80191116 |
| 27 | lysine catabolic process (GO:0006554) | 4.79002187 |
| 28 | lysine metabolic process (GO:0006553) | 4.79002187 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.78771541 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.76827632 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.73077679 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.71284861 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.67728543 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.60476945 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.57288850 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.55982299 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.55766341 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.50717288 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.49564648 |
| 40 | regulation of complement activation (GO:0030449) | 4.48196539 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.47854790 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40320195 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.40320195 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.40320195 |
| 45 | coenzyme catabolic process (GO:0009109) | 4.35769885 |
| 46 | phospholipid efflux (GO:0033700) | 4.27223649 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.25305820 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.24239834 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.24239834 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.22184212 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.22184212 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 4.15287866 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.11829076 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.11465209 |
| 55 | response to peptidoglycan (GO:0032494) | 4.09556095 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08161523 |
| 57 | negative regulation of cell killing (GO:0031342) | 4.08161523 |
| 58 | glutamate metabolic process (GO:0006536) | 4.06798752 |
| 59 | ethanol oxidation (GO:0006069) | 4.06417292 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 4.06410138 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.06101843 |
| 62 | mannose metabolic process (GO:0006013) | 4.03218861 |
| 63 | glycine metabolic process (GO:0006544) | 4.02933645 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.99695680 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 3.97371252 |
| 66 | amine catabolic process (GO:0009310) | 3.97371252 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 3.97097832 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92808135 |
| 69 | cholesterol efflux (GO:0033344) | 3.91857617 |
| 70 | cellular glucuronidation (GO:0052695) | 3.90503271 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 3.83773263 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 3.82310800 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.77190405 |
| 74 | detection of bacterium (GO:0016045) | 3.76653318 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.73160908 |
| 76 | organic acid catabolic process (GO:0016054) | 3.70803743 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.70803743 |
| 78 | drug catabolic process (GO:0042737) | 3.70734840 |
| 79 | detection of other organism (GO:0098543) | 3.69611949 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.68661354 |
| 81 | ketone body metabolic process (GO:1902224) | 3.68608422 |
| 82 | cofactor catabolic process (GO:0051187) | 3.68203997 |
| 83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67302259 |
| 84 | arginine metabolic process (GO:0006525) | 3.66930231 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.65725930 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65084729 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.64561081 |
| 88 | valine metabolic process (GO:0006573) | 3.62457173 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62050834 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62050834 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.61198548 |
| 92 | macrophage activation involved in immune response (GO:0002281) | 3.60151040 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.59274374 |
| 94 | drug transmembrane transport (GO:0006855) | 3.59026967 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.58197240 |
| 96 | fibrinolysis (GO:0042730) | 3.57762418 |
| 97 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57516230 |
| 98 | modulation by symbiont of host defense response (GO:0052031) | 3.57516230 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57516230 |
| 100 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57516230 |
| 101 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57516230 |
| 102 | modulation by symbiont of host immune response (GO:0052553) | 3.57516230 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55440210 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54273693 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 3.53772823 |
| 106 | monocarboxylic acid catabolic process (GO:0072329) | 3.52424986 |
| 107 | fatty acid oxidation (GO:0019395) | 3.51590465 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.51577107 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.50937487 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.50228495 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.48837292 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.48837292 |
| 113 | complement activation, classical pathway (GO:0006958) | 3.48511765 |
| 114 | carnitine metabolic process (GO:0009437) | 3.48504951 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48481505 |
| 116 | fatty acid catabolic process (GO:0009062) | 3.46968789 |
| 117 | lipid oxidation (GO:0034440) | 3.46162386 |
| 118 | regulation of cholesterol metabolic process (GO:0090181) | 3.45250823 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 3.37386450 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34275543 |
| 121 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25290491 |
| 122 | detection of external biotic stimulus (GO:0098581) | 3.20747681 |
| 123 | germinal center formation (GO:0002467) | 3.18027251 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 3.11479654 |
| 125 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08981345 |
| 126 | protein localization to endosome (GO:0036010) | 3.01493010 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00541727 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.98219726 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95353129 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.90557452 |
| 131 | detection of biotic stimulus (GO:0009595) | 2.87334924 |
| 132 | regulation of ARF GTPase activity (GO:0032312) | 2.86808248 |
| 133 | positive thymic T cell selection (GO:0045059) | 2.84635228 |
| 134 | detection of molecule of bacterial origin (GO:0032490) | 2.83411468 |
| 135 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82842728 |
| 136 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82524034 |
| 137 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81692064 |
| 138 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81381620 |
| 139 | regulation of mast cell degranulation (GO:0043304) | 2.80910651 |
| 140 | leukocyte aggregation (GO:0070486) | 2.80580034 |
| 141 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78879285 |
| 142 | immunoglobulin mediated immune response (GO:0016064) | 2.78468827 |
| 143 | activation of MAPKKK activity (GO:0000185) | 2.76094178 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74268122 |
| 145 | modulation by symbiont of host cellular process (GO:0044068) | 2.72769325 |
| 146 | negative regulation of innate immune response (GO:0045824) | 2.70854573 |
| 147 | response to type I interferon (GO:0034340) | 2.69750006 |
| 148 | type I interferon signaling pathway (GO:0060337) | 2.69078314 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.69078314 |
| 150 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.64123471 |
| 151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.62331164 |
| 152 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58633442 |
| 153 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.56355323 |
| 154 | defense response to protozoan (GO:0042832) | 2.55708310 |
| 155 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.54840733 |
| 156 | thymic T cell selection (GO:0045061) | 2.54580374 |
| 157 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.53789976 |
| 158 | myeloid dendritic cell differentiation (GO:0043011) | 2.53682420 |
| 159 | glycosphingolipid catabolic process (GO:0046479) | 2.53517741 |
| 160 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52708938 |
| 161 | modulation by virus of host process (GO:0019054) | 2.52447328 |
| 162 | cellular response to virus (GO:0098586) | 2.50319634 |
| 163 | negative regulation of interleukin-6 production (GO:0032715) | 2.47478685 |
| 164 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47282491 |
| 165 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47121386 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46346564 |
| 167 | apoptotic process involved in morphogenesis (GO:0060561) | 2.45190227 |
| 168 | response to laminar fluid shear stress (GO:0034616) | 2.43344247 |
| 169 | response to protozoan (GO:0001562) | 2.41218192 |
| 170 | regulation of regulated secretory pathway (GO:1903305) | 2.41003873 |
| 171 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.39204209 |
| 172 | negative regulation of granulocyte differentiation (GO:0030853) | 2.38278457 |
| 173 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.37983684 |
| 174 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.37582936 |
| 175 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.36988152 |
| 176 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36844474 |
| 177 | positive regulation of histone deacetylation (GO:0031065) | 2.36130924 |
| 178 | myeloid cell activation involved in immune response (GO:0002275) | 2.34798043 |
| 179 | cellular extravasation (GO:0045123) | 2.34213453 |
| 180 | barbed-end actin filament capping (GO:0051016) | 2.33088150 |
| 181 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32896493 |
| 182 | pinocytosis (GO:0006907) | 2.32009731 |
| 183 | T cell selection (GO:0045058) | 2.31545204 |
| 184 | negative regulation of cell size (GO:0045792) | 2.31224321 |
| 185 | regulation of necroptotic process (GO:0060544) | 2.30566155 |
| 186 | macrophage activation (GO:0042116) | 2.30531363 |
| 187 | acute-phase response (GO:0006953) | 2.29872529 |
| 188 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.29758244 |
| 189 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.27675338 |
| 190 | regulation of superoxide anion generation (GO:0032928) | 2.27647910 |
| 191 | myeloid dendritic cell activation (GO:0001773) | 2.26909810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.82582546 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.70063909 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.34762740 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06312143 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.96121402 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94536935 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.72190078 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77288108 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.54175018 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.32888190 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.60859462 |
| 12 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.60329663 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46254885 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.35186218 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31202819 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28014830 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.23524712 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19037133 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07590106 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07127301 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06717233 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01796739 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0044815 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99872268 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96855818 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83262855 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81984787 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.80868406 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.78490992 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.73279631 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71943510 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70828078 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69057869 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.68290468 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67224278 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66074682 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.62446323 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61831305 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61270589 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60980769 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59562772 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57783176 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55857288 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.55150783 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53601141 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52174856 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49439727 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48635309 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48168137 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47873990 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46766307 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45154858 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41429860 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38561998 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38545205 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35607694 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34905636 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30530991 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30333975 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29299059 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28936397 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28423873 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27758512 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27685953 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26604680 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24509449 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22608485 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22506206 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22166017 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22105252 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21657815 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20529286 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19952140 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19822374 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18449117 |
| 76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16658196 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16599967 |
| 78 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15497125 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14733557 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14733409 |
| 81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13534498 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12984511 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12920288 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12041428 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12024180 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10981916 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10707109 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09580306 |
| 89 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09452422 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09070156 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08829952 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08495159 |
| 93 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06603126 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05610996 |
| 95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03395470 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03332916 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02826081 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02665045 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02619057 |
| 100 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00438112 |
| 101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99227817 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97581806 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95981392 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93616607 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90232970 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86901931 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84140642 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83063969 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78689751 |
| 110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77252604 |
| 111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77220967 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75697658 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73204910 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73008692 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72641818 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72409228 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72314274 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71986133 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71921715 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71048179 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70702477 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69622790 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66546767 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66546767 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66180458 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66156890 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.66062270 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65737715 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65632536 |
| 130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64701641 |
| 131 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64474588 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64338249 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64190967 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63675767 |
| 135 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62816108 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62535127 |
| 137 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62303499 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61821437 |
| 139 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.59920363 |
| 140 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59667944 |
| 141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59091008 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57487062 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.57029946 |
| 144 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.54902048 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.54033410 |
| 146 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53445227 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53247379 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.53122868 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52603519 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52487874 |
| 151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51537483 |
| 152 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.50830452 |
| 153 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49034205 |
| 154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.48850350 |
| 155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48045652 |
| 156 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47749415 |
| 157 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.47224859 |
| 158 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.47164600 |
| 159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.45581796 |
| 160 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.45552600 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45474147 |
| 162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.45297565 |
| 163 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45227396 |
| 164 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.44578051 |
| 165 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44555250 |
| 166 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.43710867 |
| 167 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43433880 |
| 168 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43041346 |
| 169 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43032700 |
| 170 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.42932237 |
| 171 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.42704775 |
| 172 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.42704775 |
| 173 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42622881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.90322947 |
| 2 | MP0005360_urolithiasis | 7.25130510 |
| 3 | MP0005365_abnormal_bile_salt | 5.99213577 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.92421853 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.81364798 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08188344 |
| 7 | MP0003303_peritoneal_inflammation | 3.86251222 |
| 8 | MP0003252_abnormal_bile_duct | 3.60914776 |
| 9 | MP0009840_abnormal_foam_cell | 3.42460582 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.38364600 |
| 11 | MP0005083_abnormal_biliary_tract | 3.13939219 |
| 12 | MP0003195_calcinosis | 2.95562298 |
| 13 | MP0005332_abnormal_amino_acid | 2.86702709 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.72624254 |
| 15 | MP0008260_abnormal_autophagy | 2.70451917 |
| 16 | MP0009278_abnormal_bone_marrow | 2.46777259 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.42511640 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.13782212 |
| 19 | MP0004510_myositis | 2.13734404 |
| 20 | MP0000609_abnormal_liver_physiology | 2.13323460 |
| 21 | MP0005387_immune_system_phenotype | 2.12324185 |
| 22 | MP0001790_abnormal_immune_system | 2.12324185 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.07056880 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.02074118 |
| 25 | MP0004947_skin_inflammation | 1.96531727 |
| 26 | MP0003868_abnormal_feces_composition | 1.90719690 |
| 27 | MP0001800_abnormal_humoral_immune | 1.85838013 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.81671301 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.80305570 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.80203106 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.77817962 |
| 32 | MP0002723_abnormal_immune_serum | 1.76583225 |
| 33 | MP0001849_ear_inflammation | 1.76562168 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.76189715 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.73363957 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.67530069 |
| 37 | MP0001764_abnormal_homeostasis | 1.67325663 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.63016635 |
| 39 | MP0001819_abnormal_immune_cell | 1.62317190 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.60633963 |
| 41 | MP0000858_altered_metastatic_potential | 1.60160920 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.53923640 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.52621216 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.51153614 |
| 45 | MP0005671_abnormal_response_to | 1.50713533 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.47014823 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.47014823 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.45182680 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.43461654 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.35870432 |
| 51 | MP0002405_respiratory_system_inflammati | 1.35088876 |
| 52 | MP0003186_abnormal_redox_activity | 1.33885967 |
| 53 | MP0005451_abnormal_body_composition | 1.31553006 |
| 54 | MP0000716_abnormal_immune_system | 1.26494796 |
| 55 | MP0004858_abnormal_nervous_system | 1.25064565 |
| 56 | MP0002398_abnormal_bone_marrow | 1.23481250 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.19149550 |
| 58 | MP0009764_decreased_sensitivity_to | 1.18177855 |
| 59 | MP0009697_abnormal_copulation | 1.17577732 |
| 60 | MP0000604_amyloidosis | 1.16901060 |
| 61 | MP0000343_altered_response_to | 1.16440928 |
| 62 | MP0000598_abnormal_liver_morphology | 1.14974711 |
| 63 | MP0001873_stomach_inflammation | 1.14818511 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.11638674 |
| 65 | MP0003011_delayed_dark_adaptation | 1.11397621 |
| 66 | MP0002933_joint_inflammation | 1.08772591 |
| 67 | MP0005647_abnormal_sex_gland | 1.06736446 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.06403636 |
| 69 | MP0003279_aneurysm | 1.06226534 |
| 70 | MP0002429_abnormal_blood_cell | 1.05356496 |
| 71 | MP0009763_increased_sensitivity_to | 1.05090649 |
| 72 | MP0008469_abnormal_protein_level | 1.03588527 |
| 73 | MP0002722_abnormal_immune_system | 1.02607097 |
| 74 | MP0005375_adipose_tissue_phenotype | 0.97057027 |
| 75 | MP0003091_abnormal_cell_migration | 0.97011637 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.96804140 |
| 77 | MP0000689_abnormal_spleen_morphology | 0.95633510 |
| 78 | MP0004130_abnormal_muscle_cell | 0.95165031 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.92631993 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.92622287 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.92127913 |
| 82 | MP0001851_eye_inflammation | 0.89534888 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.89494220 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.88721282 |
| 85 | MP0001663_abnormal_digestive_system | 0.87732881 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.87619267 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.87246071 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.86312391 |
| 89 | MP0005310_abnormal_salivary_gland | 0.86088691 |
| 90 | MP0005023_abnormal_wound_healing | 0.85760536 |
| 91 | MP0003690_abnormal_glial_cell | 0.85469787 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.84660644 |
| 93 | MP0005390_skeleton_phenotype | 0.84331547 |
| 94 | MP0005408_hypopigmentation | 0.83032069 |
| 95 | MP0003329_amyloid_beta_deposits | 0.81956689 |
| 96 | MP0002254_reproductive_system_inflammat | 0.81773892 |
| 97 | MP0003879_abnormal_hair_cell | 0.81420524 |
| 98 | MP0002971_abnormal_brown_adipose | 0.81287395 |
| 99 | MP0003448_altered_tumor_morphology | 0.80991310 |
| 100 | MP0003828_pulmonary_edema | 0.79184754 |
| 101 | MP0002249_abnormal_larynx_morphology | 0.79045041 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.76904134 |
| 103 | MP0005334_abnormal_fat_pad | 0.76300376 |
| 104 | MP0005409_darkened_coat_color | 0.75890512 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.74323711 |
| 106 | MP0005535_abnormal_body_temperature | 0.74256707 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.73557706 |
| 108 | MP0005670_abnormal_white_adipose | 0.73158649 |
| 109 | MP0003724_increased_susceptibility_to | 0.72361689 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.72093206 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.71568409 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.70903110 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.70351516 |
| 114 | MP0001661_extended_life_span | 0.69916537 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.69598763 |
| 116 | MP0003866_abnormal_defecation | 0.69399135 |
| 117 | MP0001756_abnormal_urination | 0.68406421 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.66976309 |
| 119 | MP0009931_abnormal_skin_appearance | 0.66093591 |
| 120 | MP0003436_decreased_susceptibility_to | 0.65447635 |
| 121 | MP0005448_abnormal_energy_balance | 0.62876599 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.62535887 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.60303957 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.56637370 |
| 125 | MP0004043_abnormal_pH_regulation | 0.56363814 |
| 126 | MP0002928_abnormal_bile_duct | 0.54205823 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.53781181 |
| 128 | MP0002132_abnormal_respiratory_system | 0.53281458 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.53258586 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.52420154 |
| 131 | MP0005266_abnormal_metabolism | 0.52211647 |
| 132 | MP0003075_altered_response_to | 0.51470497 |
| 133 | MP0009785_altered_susceptibility_to | 0.51321892 |
| 134 | MP0006082_CNS_inflammation | 0.50316726 |
| 135 | MP0001853_heart_inflammation | 0.48802584 |
| 136 | MP0008874_decreased_physiological_sensi | 0.48692445 |
| 137 | MP0005166_decreased_susceptibility_to | 0.48566064 |
| 138 | MP0004381_abnormal_hair_follicle | 0.47332877 |
| 139 | MP0002837_dystrophic_cardiac_calcinosis | 0.45943727 |
| 140 | MP0003953_abnormal_hormone_level | 0.44869822 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.42266730 |
| 142 | MP0008873_increased_physiological_sensi | 0.42142079 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.40581650 |
| 144 | MP0001835_abnormal_antigen_presentation | 0.40324596 |
| 145 | MP0002419_abnormal_innate_immunity | 0.40252552 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.39970702 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.39310595 |
| 148 | MP0002090_abnormal_vision | 0.38876980 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.38839995 |
| 150 | MP0005025_abnormal_response_to | 0.38592994 |
| 151 | MP0004147_increased_porphyrin_level | 0.38065960 |
| 152 | MP0005395_other_phenotype | 0.37426803 |
| 153 | MP0009115_abnormal_fat_cell | 0.37378916 |
| 154 | MP0005075_abnormal_melanosome_morpholog | 0.37165004 |
| 155 | MP0001944_abnormal_pancreas_morphology | 0.35765511 |
| 156 | MP0003959_abnormal_lean_body | 0.35627630 |
| 157 | MP0003172_abnormal_lysosome_physiology | 0.34507330 |
| 158 | MP0000249_abnormal_blood_vessel | 0.34126610 |
| 159 | MP0002168_other_aberrant_phenotype | 0.33909066 |
| 160 | MP0000685_abnormal_immune_system | 0.33120565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.25926138 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.73928014 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.56686098 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.11217453 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02100588 |
| 6 | Xanthomatosis (HP:0000991) | 5.98385302 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.57613088 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30764188 |
| 9 | Complement deficiency (HP:0004431) | 4.74682987 |
| 10 | Ketosis (HP:0001946) | 4.52311495 |
| 11 | Hyperammonemia (HP:0001987) | 4.48962586 |
| 12 | Joint hemorrhage (HP:0005261) | 4.42642382 |
| 13 | Hyperglycinemia (HP:0002154) | 4.29440044 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.23634340 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.18904874 |
| 16 | Hyperglycinuria (HP:0003108) | 4.13457882 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.12959670 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.08228283 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08228283 |
| 20 | Epidermoid cyst (HP:0200040) | 4.05893832 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05181448 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.04711993 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03930182 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00319528 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.99892719 |
| 26 | Fat malabsorption (HP:0002630) | 3.98811641 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.94687586 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.80241987 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72860409 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72860409 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72860409 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70669105 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.67857563 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63527062 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58886519 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.45407944 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.45116676 |
| 38 | Abnormality of complement system (HP:0005339) | 3.42329791 |
| 39 | Ketoacidosis (HP:0001993) | 3.38161688 |
| 40 | Dysostosis multiplex (HP:0000943) | 3.36234091 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.35972469 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.34395816 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.34173064 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 3.34084459 |
| 45 | Steatorrhea (HP:0002570) | 3.12856096 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.12522133 |
| 47 | Myositis (HP:0100614) | 3.00379205 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.99507125 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97085069 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97085069 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97085069 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93823394 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.90490848 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.88176497 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88176497 |
| 56 | Metabolic acidosis (HP:0001942) | 2.83385975 |
| 57 | Myocardial infarction (HP:0001658) | 2.82738366 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76668261 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.76668261 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.76349215 |
| 61 | Orchitis (HP:0100796) | 2.76042693 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73746153 |
| 63 | Obstructive lung disease (HP:0006536) | 2.73746153 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.73648558 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.72406617 |
| 66 | Purpura (HP:0000979) | 2.70496346 |
| 67 | Cellulitis (HP:0100658) | 2.70128764 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.70073415 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.67810448 |
| 70 | Thin bony cortex (HP:0002753) | 2.67156323 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.65268573 |
| 72 | Loss of speech (HP:0002371) | 2.63579621 |
| 73 | Increased IgE level (HP:0003212) | 2.62699292 |
| 74 | Gout (HP:0001997) | 2.61812504 |
| 75 | Lethargy (HP:0001254) | 2.61738691 |
| 76 | Vascular calcification (HP:0004934) | 2.61178119 |
| 77 | Colitis (HP:0002583) | 2.59227475 |
| 78 | Gingivitis (HP:0000230) | 2.58525813 |
| 79 | Spontaneous abortion (HP:0005268) | 2.54126504 |
| 80 | Skin nodule (HP:0200036) | 2.53816919 |
| 81 | Cerebral edema (HP:0002181) | 2.48209911 |
| 82 | Increased serum ferritin (HP:0003281) | 2.48063061 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46525963 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42397123 |
| 85 | Meningitis (HP:0001287) | 2.40747436 |
| 86 | Mitral stenosis (HP:0001718) | 2.39140257 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.37258733 |
| 88 | Amyloidosis (HP:0011034) | 2.35861543 |
| 89 | Spastic diplegia (HP:0001264) | 2.34114253 |
| 90 | Acanthocytosis (HP:0001927) | 2.34034588 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.33771219 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.31684284 |
| 93 | Polygenic inheritance (HP:0010982) | 2.28984123 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 2.28489084 |
| 95 | Irritability (HP:0000737) | 2.28385761 |
| 96 | Late onset (HP:0003584) | 2.27979681 |
| 97 | Glomerulonephritis (HP:0000099) | 2.27423338 |
| 98 | Retrobulbar optic neuritis (HP:0100654) | 2.27082010 |
| 99 | Optic neuritis (HP:0100653) | 2.27082010 |
| 100 | Pancreatitis (HP:0001733) | 2.26061080 |
| 101 | Opisthotonus (HP:0002179) | 2.24463700 |
| 102 | Axonal loss (HP:0003447) | 2.24172079 |
| 103 | Brushfield spots (HP:0001088) | 2.23928867 |
| 104 | Neonatal onset (HP:0003623) | 2.23197538 |
| 105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23047368 |
| 106 | Cholelithiasis (HP:0001081) | 2.23044244 |
| 107 | Gastrointestinal inflammation (HP:0004386) | 2.20951981 |
| 108 | Vertebral compression fractures (HP:0002953) | 2.20833690 |
| 109 | Gingival bleeding (HP:0000225) | 2.20592435 |
| 110 | Thoracic kyphosis (HP:0002942) | 2.20579541 |
| 111 | Vomiting (HP:0002013) | 2.18877752 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17432656 |
| 113 | Neurofibrillary tangles (HP:0002185) | 2.16234996 |
| 114 | Cholecystitis (HP:0001082) | 2.14959781 |
| 115 | Abnormal gallbladder physiology (HP:0012438) | 2.14959781 |
| 116 | Cerebral aneurysm (HP:0004944) | 2.14091534 |
| 117 | Spontaneous hematomas (HP:0007420) | 2.11879078 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 2.11619609 |
| 119 | Recurrent fungal infections (HP:0002841) | 2.10744376 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.10127896 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 2.08708009 |
| 122 | Abnormality of the thoracic spine (HP:0100711) | 2.08246910 |
| 123 | Hyperacusis (HP:0010780) | 2.08159844 |
| 124 | J-shaped sella turcica (HP:0002680) | 2.06159109 |
| 125 | Achilles tendon contracture (HP:0001771) | 2.05626049 |
| 126 | Malnutrition (HP:0004395) | 2.05279350 |
| 127 | Nuclear cataract (HP:0100018) | 2.04462629 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 2.04312891 |
| 129 | Recurrent skin infections (HP:0001581) | 2.04213061 |
| 130 | Stridor (HP:0010307) | 2.04192265 |
| 131 | Menorrhagia (HP:0000132) | 2.03964656 |
| 132 | Pathologic fracture (HP:0002756) | 2.03868242 |
| 133 | Hypochromic microcytic anemia (HP:0004840) | 2.02137756 |
| 134 | Thrombophlebitis (HP:0004418) | 2.01992989 |
| 135 | Inflammation of the large intestine (HP:0002037) | 2.01857344 |
| 136 | Enlarged kidneys (HP:0000105) | 2.01757635 |
| 137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01478068 |
| 138 | Supranuclear gaze palsy (HP:0000605) | 1.99044949 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.99042009 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.98689950 |
| 141 | Abnormality of proline metabolism (HP:0010907) | 1.98689950 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.98314959 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.96678517 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96021899 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 1.95386021 |
| 146 | Cerebral inclusion bodies (HP:0100314) | 1.94960170 |
| 147 | Gastrointestinal stroma tumor (HP:0100723) | 1.94703200 |
| 148 | Cervical subluxation (HP:0003308) | 1.94423278 |
| 149 | Alkalosis (HP:0001948) | 1.93450611 |
| 150 | Proximal tubulopathy (HP:0000114) | 1.92423622 |
| 151 | Emphysema (HP:0002097) | 1.92220531 |
| 152 | Broad face (HP:0000283) | 1.92035556 |
| 153 | Asymmetric septal hypertrophy (HP:0001670) | 1.90087282 |
| 154 | Epistaxis (HP:0000421) | 1.89413613 |
| 155 | Increased connective tissue (HP:0009025) | 1.89126731 |
| 156 | Esophageal varix (HP:0002040) | 1.88814846 |
| 157 | Metaphyseal cupping (HP:0003021) | 1.88154584 |
| 158 | Symptomatic seizures (HP:0011145) | 1.86847824 |
| 159 | Recurrent viral infections (HP:0004429) | 1.86816541 |
| 160 | Slow saccadic eye movements (HP:0000514) | 1.86346150 |
| 161 | Vasculitis (HP:0002633) | 1.86336735 |
| 162 | Stomatitis (HP:0010280) | 1.85324524 |
| 163 | Hypochromic anemia (HP:0001931) | 1.84531703 |
| 164 | Poikilocytosis (HP:0004447) | 1.84491138 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84464993 |
| 166 | Upper limb amyotrophy (HP:0009129) | 1.84443258 |
| 167 | Distal upper limb amyotrophy (HP:0007149) | 1.84443258 |
| 168 | Pustule (HP:0200039) | 1.83652631 |
| 169 | Abnormality of the nasal mucosa (HP:0000433) | 1.81936010 |
| 170 | Distal lower limb muscle weakness (HP:0009053) | 1.81355607 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.80796136 |
| 172 | Petechiae (HP:0000967) | 1.79741152 |
| 173 | Joint stiffness (HP:0001387) | 1.79099938 |
| 174 | Abnormality of the fingertips (HP:0001211) | 1.78414558 |
| 175 | Prolonged neonatal jaundice (HP:0006579) | 1.78014989 |
| 176 | Distal lower limb amyotrophy (HP:0008944) | 1.77706554 |
| 177 | Acute hepatic failure (HP:0006554) | 1.77184015 |
| 178 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77104608 |
| 179 | Pulmonary embolism (HP:0002204) | 1.75518652 |
| 180 | Renal cortical cysts (HP:0000803) | 1.75255058 |
| 181 | Bone pain (HP:0002653) | 1.75030080 |
| 182 | Abnormality of vitamin metabolism (HP:0100508) | 1.74023883 |
| 183 | Urticaria (HP:0001025) | 1.73933516 |
| 184 | Prolonged bleeding time (HP:0003010) | 1.73344392 |
| 185 | Rickets (HP:0002748) | 1.70650992 |
| 186 | Hyperuricemia (HP:0002149) | 1.70643170 |
| 187 | Increased purine levels (HP:0004368) | 1.70643170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.59215978 |
| 2 | SIK1 | 4.12735675 |
| 3 | ERN1 | 4.03037359 |
| 4 | FGFR4 | 3.81444505 |
| 5 | PRPF4B | 3.17447124 |
| 6 | INSRR | 3.11950954 |
| 7 | FLT3 | 3.04085673 |
| 8 | TAOK3 | 2.82089569 |
| 9 | RIPK4 | 2.43317668 |
| 10 | TYK2 | 2.29957387 |
| 11 | SMG1 | 2.23883907 |
| 12 | PKN2 | 2.05318780 |
| 13 | TRIB3 | 2.03852654 |
| 14 | NME2 | 1.91872458 |
| 15 | RIPK1 | 1.88713648 |
| 16 | PIK3CG | 1.88477122 |
| 17 | MAP3K13 | 1.76398536 |
| 18 | ERBB4 | 1.74683996 |
| 19 | IRAK4 | 1.66638140 |
| 20 | TNK2 | 1.64768887 |
| 21 | ICK | 1.61874286 |
| 22 | TBK1 | 1.57689880 |
| 23 | PTK6 | 1.57036051 |
| 24 | MAPK15 | 1.52650982 |
| 25 | MAP2K4 | 1.52227546 |
| 26 | TAOK1 | 1.48516008 |
| 27 | MAPK11 | 1.44780863 |
| 28 | TAOK2 | 1.44632164 |
| 29 | JAK1 | 1.44007496 |
| 30 | MST1R | 1.43654165 |
| 31 | MAP2K3 | 1.42148583 |
| 32 | KDR | 1.40880935 |
| 33 | EEF2K | 1.40791957 |
| 34 | CDC42BPA | 1.40620733 |
| 35 | MARK2 | 1.35644887 |
| 36 | EPHB1 | 1.31448912 |
| 37 | SIK2 | 1.30646802 |
| 38 | SIK3 | 1.30296953 |
| 39 | PINK1 | 1.28097708 |
| 40 | JAK2 | 1.28075888 |
| 41 | KIT | 1.23505600 |
| 42 | CSF1R | 1.21772354 |
| 43 | TTN | 1.19904499 |
| 44 | MAP4K1 | 1.19822745 |
| 45 | PRKD2 | 1.15481636 |
| 46 | JAK3 | 1.14062065 |
| 47 | MAP3K7 | 1.11478415 |
| 48 | IKBKE | 1.10925062 |
| 49 | MAP3K6 | 1.10128299 |
| 50 | ARAF | 1.09462481 |
| 51 | FGFR2 | 1.05364154 |
| 52 | FES | 1.02700668 |
| 53 | CDK12 | 1.02093871 |
| 54 | ABL2 | 1.01463646 |
| 55 | NEK9 | 1.01047219 |
| 56 | PRKAA2 | 0.97665977 |
| 57 | ZAP70 | 0.97398853 |
| 58 | KSR2 | 0.96597809 |
| 59 | RPS6KA2 | 0.92940599 |
| 60 | CAMK1D | 0.92285546 |
| 61 | MAPK12 | 0.91733051 |
| 62 | GRK6 | 0.89977019 |
| 63 | MAP3K14 | 0.89581199 |
| 64 | TIE1 | 0.88759959 |
| 65 | FRK | 0.87609835 |
| 66 | MAPK4 | 0.87058665 |
| 67 | RPS6KL1 | 0.86785866 |
| 68 | RPS6KC1 | 0.86785866 |
| 69 | BRAF | 0.85901557 |
| 70 | HCK | 0.84578205 |
| 71 | BTK | 0.83890559 |
| 72 | BLK | 0.83341612 |
| 73 | LATS1 | 0.82933286 |
| 74 | EPHA3 | 0.80790317 |
| 75 | MET | 0.79246663 |
| 76 | HIPK2 | 0.77301917 |
| 77 | TESK2 | 0.76123618 |
| 78 | IRAK3 | 0.75827463 |
| 79 | TGFBR2 | 0.74047820 |
| 80 | SGK3 | 0.73205036 |
| 81 | CSK | 0.72202969 |
| 82 | PRKD3 | 0.70009986 |
| 83 | PIM2 | 0.69643563 |
| 84 | BMX | 0.68521522 |
| 85 | DAPK2 | 0.68408841 |
| 86 | MAP2K6 | 0.68006312 |
| 87 | RPS6KA6 | 0.67979621 |
| 88 | MATK | 0.66831561 |
| 89 | NLK | 0.64351030 |
| 90 | PRKCZ | 0.63540053 |
| 91 | FGR | 0.62832867 |
| 92 | CDK4 | 0.62690319 |
| 93 | MAP3K3 | 0.62477373 |
| 94 | DDR2 | 0.62347792 |
| 95 | MTOR | 0.60673482 |
| 96 | GRK1 | 0.60285406 |
| 97 | PRKACG | 0.59431792 |
| 98 | SGK494 | 0.59245426 |
| 99 | SGK223 | 0.59245426 |
| 100 | PRKCQ | 0.59184964 |
| 101 | ITK | 0.58566315 |
| 102 | TESK1 | 0.58161394 |
| 103 | PDPK1 | 0.57615235 |
| 104 | CAMK2G | 0.57502357 |
| 105 | PRKCH | 0.57438571 |
| 106 | GSK3A | 0.56702730 |
| 107 | IRAK1 | 0.56688120 |
| 108 | PAK4 | 0.56138530 |
| 109 | SGK2 | 0.56005697 |
| 110 | LCK | 0.55512614 |
| 111 | MARK3 | 0.55204882 |
| 112 | MYLK | 0.53493798 |
| 113 | PDGFRA | 0.50130454 |
| 114 | PRKAA1 | 0.49085331 |
| 115 | LRRK2 | 0.48413898 |
| 116 | MOS | 0.48064252 |
| 117 | PIK3CA | 0.47817461 |
| 118 | ERBB2 | 0.47411627 |
| 119 | TYRO3 | 0.46436456 |
| 120 | FGFR3 | 0.45857383 |
| 121 | PKN1 | 0.45358874 |
| 122 | MAP2K2 | 0.44926812 |
| 123 | DYRK1B | 0.44375063 |
| 124 | MAP3K8 | 0.43955773 |
| 125 | IRAK2 | 0.43733656 |
| 126 | PDK1 | 0.43459767 |
| 127 | CHUK | 0.42568096 |
| 128 | CAMK1G | 0.42472910 |
| 129 | SYK | 0.41146175 |
| 130 | MAP3K11 | 0.40498817 |
| 131 | RPS6KA1 | 0.39900524 |
| 132 | IGF1R | 0.39122608 |
| 133 | RET | 0.38362100 |
| 134 | LYN | 0.36014856 |
| 135 | CAMK4 | 0.35904074 |
| 136 | PTK2 | 0.35291207 |
| 137 | STK16 | 0.34058188 |
| 138 | OXSR1 | 0.33354024 |
| 139 | WNK4 | 0.33235094 |
| 140 | CSNK1G1 | 0.30471565 |
| 141 | MAP3K1 | 0.29778071 |
| 142 | TEC | 0.29766928 |
| 143 | CAMKK1 | 0.29211831 |
| 144 | EGFR | 0.29129196 |
| 145 | IKBKB | 0.28249756 |
| 146 | MAP3K10 | 0.28213984 |
| 147 | MAPK7 | 0.27762127 |
| 148 | CAMKK2 | 0.26127710 |
| 149 | ABL1 | 0.25346933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37894068 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43899942 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24279092 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02925009 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87943722 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.85186991 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65415158 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64559721 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57690226 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57673973 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55213612 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46996427 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42817282 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21630365 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.21361546 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18033299 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11863984 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.10749119 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.07912747 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99294382 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98043276 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97803450 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95117249 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89860932 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87881052 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77531229 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76630281 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74431123 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73288472 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72328754 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71162398 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.70734826 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68986857 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68224477 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67853908 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61622959 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61289107 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60600354 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58406643 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56367670 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54927959 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54767096 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.53960946 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51543109 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51459103 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49893505 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.47759196 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.46879597 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46624732 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45517326 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40608289 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40130864 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39778283 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.34677454 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32830025 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30925012 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30312197 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29172582 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28221179 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27765218 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26063460 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.25705353 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 1.24699339 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22909917 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 1.21660960 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20681268 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19404616 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17186963 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16352402 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15073733 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13744004 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13377025 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 1.09949873 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08336322 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06426306 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04371885 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03869300 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00781450 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99231957 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98998014 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98584598 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95400476 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93514143 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91067332 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.91050107 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89227141 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.89033758 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88827409 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88562551 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.88360248 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87955603 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.87753763 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85474368 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84778475 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.82901305 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82284146 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81581921 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81268953 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80261122 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80046001 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.79465775 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78544409 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77097409 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76884701 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76471738 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74735127 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74282533 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73017677 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71964307 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71903296 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.71216036 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70930926 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.70414827 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68260039 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67880414 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67098568 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.66284932 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.66056047 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65568452 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.65262723 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64983325 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62905422 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61283375 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59934325 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58646170 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58207193 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57507195 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53275836 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52954544 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51596996 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51448827 |
| 132 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50704224 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49938897 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49224356 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.49182493 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47756665 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46947050 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46394269 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46300433 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39487685 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.30595767 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28561148 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28154849 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27406732 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.26919850 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26343366 |
| 147 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22892087 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21548381 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19064327 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06078167 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04377279 |
| 152 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02433157 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01022756 |
| 154 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1792857 |
| 155 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1673763 |
| 156 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1636138 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1614270 |
| 158 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1509526 |
| 159 | Pertussis_Homo sapiens_hsa05133 | -0.1507667 |
| 160 | Protein export_Homo sapiens_hsa03060 | -0.1478744 |
| 161 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1303565 |
| 162 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1076706 |
| 163 | Hepatitis C_Homo sapiens_hsa05160 | -0.0959627 |
| 164 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0928829 |
| 165 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0879786 |
| 166 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0814367 |
| 167 | Lysosome_Homo sapiens_hsa04142 | -0.0582293 |
| 168 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0509875 |
| 169 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0431065 |
| 170 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0197267 |
| 171 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0111273 |
| 172 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0099697 |

